We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.
We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.
We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.
Impact Health is a mission-driven health policy and strategic consulting firm dedicated to improving health and well-being for all.
OUR SERVICES
Strategic Planning
Integrate mission-aligned policy expertise and political acumen into planning and executing your goals.
Government Contracting
Track record of success supporting states and municipalities in innovating or launching new programs.
Our proprietary method for tracking, aggregating, and analyzing state policy trends.
If you believe that every American deserves to be healthy and well, contact Impact Health Policy Partners to learn how our expertise can help you achieve your goals.
Policy Hub, managed by Impact Health Policy Partners, is the only comprehensive database of Federal health policy developments, cataloged by over 200 healthcare topics and programs. Regulations, reimbursement, grants, ACA implementation, hearing summaries, CRS Reports, pending legislation – you get it all here, with comprehensive, expert analysis.
Agency Policy Roundup: Leadership Upheaval, AI Modernization, Gene Editing Oversight, and New Regulatory Initiatives
The Food and Drug Administration (FDA) entered another period of uncertainty this week following the resignation of Commissioner Marty Makary after just 13 months leading the agency. Dr. Makary’s departure comes ahead of a Senate Appropriations Committee hearing scheduled for tomorrow on the FDA’s budget and follows months of internal disruption, including mass layoffs, persistent turnover among senior officials, tensions… (Colocho, May 12, 2026) #Artificial Intelligence, #Coverage Decisions, #Food and Drug Administration, #Tobacco
Reproductive Health Roundup: Supreme Court Temporarily Preserves Access to Mifepristone as FDA Leadership Shakeup Creates Opening for Stricter Oversight of FDA Mifepristone Review
This week brought major developments related to medication abortion access and federal reproductive health policy. For now, the Supreme Court has temporarily preserved nationwide access to mifepristone through telehealth prescribing and mail distribution by extending its administrative stay in Louisiana v. FDA through May 14 while the Court considers whether lower court restrictions should remain in effect. At the same… (Eisen, May 12, 2026) #Health Equity, #Women’s Health